Retatrutide, a experimental dual stimulator of the GLP-1 target and glucose-dependent insulinotropic polypeptide (GIP) binding site , is showing promising results in early human studies. Ongoing research https://madesocials.com/story6910497/retatrutide-emerging-research-and-possible-clinical-applications